CTOs on the Move

OrthoFX

www.orthofx.com

 
OrthoFX have the best materials technology in the industry, due in large part to Loc Phan, the key scientist behind developing the first ever clear aligner. We are committed to continued polymer technology innovation by hiring a team of industry experts like Loc to understand your needs and pain points, and we can`t do it without your partnership.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.orthofx.com
  • 48890 Milmont Dr 101D
    Fremont, CA USA 94538
  • Phone: 415.936.0006

Executives

Name Title Contact Details

Funding

OrthoFX raised $13M on 07/22/2020

Similar Companies

RadNet

RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 340+ owned and/or operated outpatient imaging centers. RadNet`s core markets include California, Delaware, Maryland, New Jersey, and New York. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 7,300 employees.

Salina Regional Health Center

Salina Regional Health Center offers rehabilitation services to a wide array of patients. We provide Physical Therapy, Occupational Therapy, Recreational Therapy, Speech Therapy, and Rehabilitation Nursing to many ages.

LiteCure

LiteCure is a Newark, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Infinity Rehab

Infinity Rehab is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Infinity Rehab is based in Wilsonville, OR. You can find more information on Infinity Rehab at www.infinityrehab.com

Framingham Heart Study

Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.